menu

Which Resected Stage II Melanoma Patients Benefit from Adjuvant ICI Therapy?

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Resectable Melanoma: New & Emerging Adjuvant Treatments

Which Resected Stage II Melanoma Patients Benefit from Adjuvant ICI Therapy?

MinuteCE®
ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Take 1 Minute Challenge
1 Minute Challenge Completed
1.00 credits
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Episodes
Presenters
Documents
Comments
  • Overview

    This program is designed to improve clinicians’ knowledge of the latest clinical trial data surrounding the use of immunotherapy for the adjuvant treatment of patients with melanoma. The program addresses clinical challenges faced by oncologists/surgeons, including selecting appropriate patients, determining optimal treatment schedules and dosing, and managing toxicity.

  • Target Audience

    This activity has been designed to meet the educational needs of the interprofessional team, including physicians, nurses, pharmacists, medical oncologists, and surgeons involved in the management of patients with melanoma.

  • Learning Objectives

    After participating in this educational activity, participants should be better able to: 

    • Interpret the efficacy and safety data of clinical trials related to the adjuvant treatment for stage IIB/IIC melanoma 
    • Interpret the efficacy and safety data of clinical trials related to the adjuvant treatment for stage III/IV melanoma 
    • Optimize the use of adjuvant treatment in patients with melanoma by considering the risks and benefits of use and identifying which patients would benefit the most from adjuvant treatment 
  • Accreditation and Credit Designation Statements

    In support of improving patient care, this activity has been planned and implemented by Global Learning Collaborative (GLC) and TotalCME, Inc. GLC is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

    This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

  • Faculty Disclosure of Commercial Relationships

    Disclosure Policy
    In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all educational programs. 

    The following faculty have disclosed:

    Nikhil I. Khushalani, MD, faculty for this educational event, is a contracted researcher for BMS, Merck, Celgene, Novartis, GSK, HUYA, Regeneron, Replimune, and Modulation Therapeutics; holds ownership interest in Bellicum, Amarin, and Ascensus Surgical; and receives consulting fees from AstraZeneca,  BMS, Castle Biosciences, Genzyme, Incyte, Instill Bio, Iovance, Jounce Therapeutics, Merck, Nektar, Novartis, and Regeneron.  

    Tara C. Mitchell, MD, faculty for this educational event, is a contracted researcher for BMS, Merck, and Incyte; and receives consulting fees from BMS, GigaGen, Merck, Pliant, and Pfizer.  

  • Planners and Managers Disclosure List

    The following planners/reviewers/managers have disclosed:

    Megan Reimann, PharmD, BCOP, planner for this educational event, has no relevant financial relationships with ineligible companies.

    William Mencia, MD, FACEHP, CHCP, reviewer for this educational event, has no relevant financial relationships with ineligible companies.

    TotalCME, Inc. planners and managers have no relevant commercial relationships to disclose.

    All the relevant financial relationships for these individuals have been mitigated.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and TotalCME, Inc. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of MedEd On The Go you are subject to the terms and conditions of use, including copyright and licensing restrictions, of that site.

    Reproduction Prohibited
    Reproduction of this material is not permitted without written permission from the copyright owner.

  • Acknowledgment

    This activity is supported by a independent educational grants from Bristol Myers Squibb and Merck Sharp & Dohme LLC.

    Jointly provided by Global Learning Collaborative (GLC) and TotalCME, Inc.

  • Fee Statement

    A computer or smartphone with broadband internet access with cookies enabled, sound card and speakers are required. Smartphone mobile data rates will apply if viewing without a wifi mobile connection. Adobe PDF Reader is necessary to print your certificate and this plug-in is free and available from the Adobe website.

  • Instructions for Completion

    During the period 7/17/2023 through 7/17/2024, registered participants wishing to receive continuing education credit for this activity must follow these steps:
    1. Read the learning objectives and faculty disclosures.
    2. Answer a pre-program question.
    3. View the program.
    4. Complete the post-test with a score of 100%. 
    5. Complete activity evaluation.
    6. Apply for credit and either bank your credits or print your certificate.

    For Pharmacists: Upon successfully completing the post-test with a score of 100% and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service. This may require you to add or update the e-profile ID/date of birth information saved in your account.

  • System Requirements

    • Supported Browsers (2 most recent versions):
      • Google Chrome for Windows, Mac OS, iOS, and Android
      • Apple Safari for Mac OS and iOS
      • Mozilla Firefox for Windows, Mac OS, iOS, and Android
      • Microsoft Edge for Windows
    • Recommended Internet Speed: 5Mbps+

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

Schedule15 Jun 2024